In a free market, there would be cheap generic alternatives. Epinephrine itself isn't expensive at all (around a dollar a dose), and the autoinjector was patented in 1977, making it long-expired (though modifications of the design are covered by newer patents).

There are other examples, such as complex surgeries that would illustrate the point you're trying to make better.